New hemostatic agent: the effect of Ankaferd Blood Stopper on healing wounds in experimental skin incision model

To conduct a histopathological evaluation of the effects of Ankaferd Blood Stopper (ABS) on healing wounds in a rabbit skin incision model. Materials and methods: Incisions were performed on the backs of rabbits. The first incision was allowed to undergo normal secondary healing. ABS (1 mL) was applied to the second incision, which was subsequently allowed to undergo secondary healing. The third incision was sutured. ABS (1 mL) was applied to the fourth incision, which was subsequently sutured. During the wound healing period, the histopathologic signs of ulceration, inflammation, the proliferative phase, and the extent of early remodeling were comparatively evaluated by performing biopsies on days 5, 10, and 30. Results: For all of the ABS-treated wounds, the appearance of the cavities during the early stage and the disappearance of the cavities during the late stage were observed. In addition, on days 5-10, the inflammatory granulation tissue in the ABS-treated wounds was less than in the normal wounds. By day 30, all of the wounds had achieved the same symptomatic state. Conclusion: As ABS does not exert any negative effects on wound healing, this agent is a secure and effective method for achieving hemostasis.

New hemostatic agent: the effect of Ankaferd Blood Stopper on healing wounds in experimental skin incision model

To conduct a histopathological evaluation of the effects of Ankaferd Blood Stopper (ABS) on healing wounds in a rabbit skin incision model. Materials and methods: Incisions were performed on the backs of rabbits. The first incision was allowed to undergo normal secondary healing. ABS (1 mL) was applied to the second incision, which was subsequently allowed to undergo secondary healing. The third incision was sutured. ABS (1 mL) was applied to the fourth incision, which was subsequently sutured. During the wound healing period, the histopathologic signs of ulceration, inflammation, the proliferative phase, and the extent of early remodeling were comparatively evaluated by performing biopsies on days 5, 10, and 30. Results: For all of the ABS-treated wounds, the appearance of the cavities during the early stage and the disappearance of the cavities during the late stage were observed. In addition, on days 5-10, the inflammatory granulation tissue in the ABS-treated wounds was less than in the normal wounds. By day 30, all of the wounds had achieved the same symptomatic state. Conclusion: As ABS does not exert any negative effects on wound healing, this agent is a secure and effective method for achieving hemostasis.

___

  • Aysan E, Bektas H, Ersoz F, Sari S, Kaygusuz A, Huq GE. Ability of the ankaferd blood stopper® to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med 2010; 3: 186–91.
  • Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 2010; 15: 329–36.
  • Beyazit Y, Kekilli M, Haznedaroglu IC, Kayacetin E, Basaranoglu M. Ankaferd hemostat in the management of gastrointestinal hemorrhages. World J Gastroenterol 2011; 17: 3962–70.
  • Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: 163–70.
  • Sheela ML, Ramakrishna MK, Salimath BR. Angiogenic and proliferative effects of the cytokine VEGF in Erlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol 2006; 6: 494–8.
  • Lee SJ, Umano K, Shibamoto T, Lee KG. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem 2005; 91: 131–7.
  • Matsuda H, Ando S, Kato T, Morikawa T, Yoshikawa M. Inhibitors from the rhizomes of Alpinia officinarum on production of nitric oxide in lypopolysaccharide activated macrophages and the structural requirements of diarylheptanoids for activity. Bioorg Med Chem 2006; 14: 138– 42.
  • Testai L, Chericoni S, Calderone V, Nencioni G, Nieri P, Morelli I, Martinotti E. Cardiovascular effects of Urtica dioica L. (Urticaceae) roots extracts: in vitro and in vivo pharmacological studies. J Ethnopharmacol 2002; 81: 105–9.
  • Kosar A, Cipil HS, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Ercetin S, Kirazli S, Firat HC. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat- bleeding model. Blood Coagul Fibrin 2009; 20: 185–90.
  • Bilgili H, Kosar A, Kurt M, Onal IK, Goker H, Captug O, Shorbagi A, Turgut M, Kekilli M, Kurt OK et al. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Med Princ Pract 2009; 18: 165–9.
  • Kose R, Sogut O, Demir T, Koruk I. Hemostatic efficacy of folkloric medicinal plant extract in a rat skin bleeding model. Dermatol Surg 2012; 38: 760–6.
  • Kılıçgün A, Sarıkaş NG, Korkmaz T, Saydam Ö, Boran Ç, Boztaş G. Effect of Ankaferd Blood Stopper on air leakage in the lung and prevention of bleeding: an experimental study. J Cardiothorac Surg 2011; 6: 20.
  • Kilic O, Gonen M, Acar K, Yurdakul T, Avunduk MC, Esen HH, Oz M. Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial. BJU Int 2010; 105: 1722–5.
  • Huri E, Akgül T, Ayyıldız A, Ustün H, Germiyanoğlu C. Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial. J Urol 2009; 181: 2349–54.
  • Karakaya K, Ucan HB, Tascilar O, Emre AU, Cakmak GK, Irkorucu O, Ankarali H, Comert M. Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration. J Invest Surg 2009, 22: 201–6.
  • İşler SC, Demircan S, Cakarer S, Cebi Z, Keskin C, Soluk M, Yüzbaşıoğlu E. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18: 409–14.
  • Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol 2009; 73: 1742–5.
  • Teker AM, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 2010; 267: 1377–81.
  • Kurt M, Akdogan M, Onal IK, Kekilli M, Arhan M, Shorbagi A, Aksu S, Kurt OK, Haznedaroglu IC. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis 2010; 42: 196–9.
  • Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc 2010; 71: 873–5.
  • Zulfikar OB, Emiroglu HH, Kebudi R. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation. Dig Liver Dis 2011; 43: 247–8.
  • Al B, Yildirim C, Cavdar M, Zengin S, Buyukaslan H, Kalender ME. Effectiveness of Ankaferd blood stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions. Saudi Med J 2009; 30: 1520–5.
  • Huri E, Akgül T, Ayyildiz A, Germiyanoğlu C. Hemostasis in retropubic radical prostatectomy with Ankaferd Blood Stopper: a case report. Kaohsiung J Med Sci 2009; 25: 445–7.
  • Guler M, Maralcan G, Kul S, Baskonus I, Yilmaz M. The efficacy of Ankaferd Blood Stopper for the management of bleeding following total thyroidectomy. J Invest Surg 2011; 24: 205–10.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Prevalence study of genital tract infections in pregnant women referred to health centers in Iran

Mahmoud MOBASHERI, Narges Saeedi VARNAMKHAST, Ali KARIMI, Shayesteh BANAEIYAN

Anti TNF-α therapy might be responsible for an increased incidence of varicocele in patients with ankylosing spondylitis

Mahmut YENER, Mehmet UMUL, Elif Nisa ÜNLÜ, Yunus UGAN, Meltem ÇETİN, Bumin DEĞİRMENCİ, Bünyamin KISACIK, Mustafa KAYAN, Aykut Recep AKTAŞ, Ömer YILMAZ

Relationship of admission neutrophil-to-lymphocyte ratio with in-hospital mortality in patients with acute type-I aortic dissection

Relationship of admission neutrophil-to- Dissection

Epidemiology of uveitis in a referral hospital in Turkey

Müge Pınar ÇAKAR ÖZDAL, Alper YAZICI, Melek TÜFEK, Faruk ÖZTÜRK

A comparison of the effects of hyperbaric and isobaric bupivacaine spinal anesthesia on hemodynamics and heart rate variability

Mehmet TOPTAŞ, Sinan UZMAN, İlke İŞİTEMİZ, Tümay Uludağ YANARAL, İbrahim AKKOÇ, Gülşen BİCAN

Tc-99m MDP bone scintigraphy in the evaluation of the joint damage in asymptomatic alpine ski racers

Erhan VAROĞLU, Mustafa YILDIRIM, Recep GÜRSOY, Bedri SEVEN, Hatice USLU, Şirzat ÇOĞALGİL, Fatih KIYICI

Evaluation of 48-week response of treatment-naive chronic hepatitis B patients to 0.5 mg/day entecavir

Servet KÖLGELİER, Nazlım Aktuğ DEMİR, Serap ÖZÇİMEN, Şua SÜMER

Intrathoracic Castleman disease

Pınar BIÇAKÇIOĞLU, Selim Şakir Erkmen GÜLHAN, Leyla Nesrin ACAR, Yetkin AĞAÇKIRAN, Şeref ÖZKARA, Sadi KAYA, Nurettin KARAOĞLANOĞLU

Comparison of disc and body volumes in degenerated and nondegenerated lumbar discs: a stereological study

Tuncay KANER, Ahmet SONGUR, Muhsin TOKTAŞ, Ozan Alper ALKOÇ, Olcay ESER, Mustafa EFENDİOĞLU

Assessment of left ventricular function by strain–strain rate echocardiography in patients with celiac disease

Cenk SARI, Aylin DEMİREZER BOLAT, Fatma Ebru AKIN, Nihal AKAR BAYRAM, Sevil ÖZER SARI, Serdal BAŞTUĞ, Emine BİLEN, Hüseyin AYHAN, Telat KELEŞ, Tahir DURMAZ, Osman ERSOY, Engin BOZKURT